OR4E2 Activators
Activation of OR4E2 is tightly regulated through intracellular signaling cascades, predominantly involving the second messenger cyclic adenosine monophosphate (cAMP). Compounds that elevate intracellular cAMP levels are therefore central to enhancing OR4E2 activity. Direct stimulation of adenylyl cyclase catalyzes the conversion of ATP to cAMP, effectively amplifying the signal transduction process that is fundamental for the proper function of OR4E2 in olfactory sensory neurons. The presence of cAMP analogs serves to mimic the effect of naturally produced cAMP by the cell, thus directly potentiating the signaling pathways that activate OR4E2. These cAMP analogs provide a persistent signal that can withstand the cellular mechanisms typically responsible for the breakdown of cAMP, ensuring prolonged activation of OR4E2.
Inhibition of phosphodiesterases (PDEs) represents another strategic avenue to increase cAMP levels and thus indirectly support the activation of OR4E2. By blocking the degradation of cAMP, PDE inhibitors sustain elevated levels of this crucial second messenger within olfactory neurons. This biochemical mechanism facilitates a more robust and sustained signaling environment, conducive to the activation of OR4E2. Moreover, certain molecules can selectively inhibit specific PDE isoforms, thereby providing a means to fine-tune the cellular response and enhance OR4E2 activity with greater specificity.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
IBMX | 28822-58-4 | sc-201188 sc-201188B sc-201188A | 200 mg 500 mg 1 g | $260.00 $350.00 $500.00 | 34 | |
Phosphodiesterase inhibitor that prevents cAMP breakdown, resulting in increased cAMP levels which may augment OR4E2 signal transduction by sustaining the second messenger within olfactory neurons. | ||||||
Dibutyryl-cAMP | 16980-89-5 | sc-201567 sc-201567A sc-201567B sc-201567C | 20 mg 100 mg 500 mg 10 g | $47.00 $136.00 $492.00 $4552.00 | 74 | |
A cAMP analog that is resistant to degradation and can mimic the effect of cAMP, thereby potentially enhancing OR4E2-mediated signal transduction. | ||||||
Theophylline | 58-55-9 | sc-202835 sc-202835A sc-202835B | 5 g 25 g 100 g | $20.00 $32.00 $85.00 | 6 | |
This methylxanthine inhibits phosphodiesterases, leading to increased cAMP levels and possibly potentiating OR4E2 signaling. | ||||||
Caffeine | 58-08-2 | sc-202514 sc-202514A sc-202514B sc-202514C sc-202514D | 50 g 100 g 250 g 1 kg 5 kg | $33.00 $67.00 $97.00 $192.00 $775.00 | 13 | |
A phosphodiesterase inhibitor that could increase intracellular cAMP levels, potentially enhancing OR4E2 signaling by preventing cAMP degradation. | ||||||
Rolipram | 61413-54-5 | sc-3563 sc-3563A | 5 mg 50 mg | $77.00 $216.00 | 18 | |
Selective phosphodiesterase-4 inhibitor, increases intracellular cAMP by preventing its breakdown, which could support OR4E2 activity in olfactory signal transduction. | ||||||
Zaprinast (M&B 22948) | 37762-06-4 | sc-201206 sc-201206A | 25 mg 100 mg | $105.00 $250.00 | 8 | |
Phosphodiesterase inhibitor that may raise cAMP levels, possibly amplifying OR4E2 signaling pathways by maintaining elevated levels of this second messenger. | ||||||
Vinpocetine | 42971-09-5 | sc-201204 sc-201204A sc-201204B | 20 mg 100 mg 15 g | $55.00 $214.00 $2400.00 | 4 | |
Inhibits phosphodiesterase type 1, potentially leading to increased cAMP levels, which may enhance the functional activity of OR4E2 in the olfactory signaling pathways. | ||||||
Cilostamide (OPC 3689) | 68550-75-4 | sc-201180 sc-201180A | 5 mg 25 mg | $92.00 $357.00 | 16 | |
Phosphodiesterase 3 inhibitor that increases cAMP levels, which could lead to enhanced OR4E2 signaling in olfactory neurons by prolonging the cAMP signal. | ||||||
Milrinone | 78415-72-2 | sc-201193 sc-201193A | 10 mg 50 mg | $165.00 $697.00 | 7 | |
This phosphodiesterase 3 inhibitor could increase cAMP concentrations, potentially amplifying OR4E2 signaling by sustaining the second messenger signal in olfactory neurons. | ||||||
PGE2 | 363-24-6 | sc-201225 sc-201225C sc-201225A sc-201225B | 1 mg 5 mg 10 mg 50 mg | $57.00 $159.00 $275.00 $678.00 | 37 | |
Activates adenylate cyclase via its receptors, leading to increased cAMP levels, which may subsequently enhance OR4E2-mediated olfactory signal transduction. | ||||||